Cargando…
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
Pancreatic cancer is the third leading cause of cancer mortality in both men and women in the United States, with poor response to current standard of care, short progression-free and overall survival. Immunotherapies that target cytotoxic T lymphocyte antigen-4, programmed cell death protein-1, and...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465012/ https://www.ncbi.nlm.nih.gov/pubmed/28638792 http://dx.doi.org/10.5306/wjco.v8.i3.230 |